Should I buy Clorox (CLX) stock or is it too late?
⭐ The most reliable of them, either direction: Evercore ISI Group — 69% of its targets hit on this sector (129 calls tested). It aims for $99 (+17 %), call made on August 5, 2026, maturing on August 5, 2027 (70 d ago).
Firm-by-firm track record on Clorox
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barclays | 61 % | +8.8 % | 28 | $86 +2% |
| Morgan Stanley | 53 % | -1.9 % | 17 | $110 +30% |
| Wells Fargo | 43 % | -2.2 % | 14 | $85 +1% |
| JP Morgan | 30 % | -8.4 % | 10 | $95 +12% |
| UBS | 46 % | -9.4 % | 13 | $105 +24% |
| Credit Suisse | 56 % | +2.5 % | 9 | — |
| DA Davidson | 33 % | -7.4 % | 6 | — |
✅ Reasons to believe
- Median price target $97, i.e. +15% from the current price ($84).
- The most reliable firm on CLX, Evercore ISI Group (75% hit rate, 4 scored calls), targets $99 (call made on August 4, 2026, maturing on August 4, 2027) (+17%) in its most recent call, and $115 (call made on February 4, 2026, maturing on February 4, 2027) (+36%) in the one coming due soonest.
- Pays a dividend (5.1% yield), raised for 22 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~18) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 10 ratings, 7 are neutral and 3 are sells.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on CLX
Median target $97 (+15%) · 10 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Clorox now?
We won't decide for you. The facts: 0% of analysts rate it a buy, median target $97 (+15%), and Evercore ISI Group (most reliable on CLX, 75%) targets $99. Weigh that against valuation (P/E ~18). This is not personalized advice.
Is it too late to invest in Clorox?
Not according to analysts: the median target ($97) is still +15% above the current price ($84) (most reliable on CLX: Evercore ISI Group, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Clorox still worth investing in?
It depends on the gap between the price ($84) and its estimated value: analysts target $97 on median (+15%), with 0% buys (most reliable on CLX: Evercore ISI Group, 75%). Cross-check with their real reliability on CLX and the cautions above. Information, not advice.
What's the main risk in buying CLX?
The consensus is not unanimous: of 10 ratings, 7 are neutral and 3 are sells.
→ Go deeper: the full Clorox profile (consensus, analyst reliability, price target, performance).